Oracle Corporation
09/23/2024 | Press release | Distributed by Public on 09/23/2024 07:12
Xaira Therapeutics selects OCI to accelerate its AI drug discovery ...
Xaira Therapeutics is using Oracle Cloud Infrastructure (OCI) to accelerate its mission to reimagine the way medicines are discovered and developed through the end-to-end application of emerging AI technologies. Xaira is already operational with industry-leading GPU capacity, powered by OCI.
Xaira and OCI
A joint incubation of ARCH Venture Partners and Foresite Labs, Xaira launched in April 2024 and is led by Dr. Marc Tessier-Lavigne, former chief scientific officer of Genentech and former president of Rockefeller and Stanford Universities. Xaira was cofounded by Dr. David Baker of the UW Medicine Institute for Protein Design.
Xaira brings together three core elements: Advanced machine learning (ML) research, expansive data generation to power new models, and robust therapeutic product development. Xaira's advances in biological ML are underpinned by the company's ability to generate, integrate, and learn from vast multidimensional data sets that comprehensively characterize disease-relevant biology at all scales, from molecules to people.
The OCI Supercluster provides ultra-low-latency cluster networking, high-performance computing (HPC) storage, and OCI Compute bare metal instances to train large, complex models at scale. Oracle's dedicated engineering support team works with customers through the entire deployment, from planning to launch, to help ensure success.
"OCI's services have been instrumental in speeding our path forward," said Hetu Kamisetty, Ph.D., cofounder of Xaira Therapeutics. "We particularly appreciate the deep engagement from OCI's engineering team."
"Xaira has put together a remarkable team of experts to rethink the drug discovery and development process and we look forward to continuing to support them," said Mahesh Thiagarajan, executive vice president, Oracle Cloud Infrastructure. "With the support of OCI, Xaira has been able to build a cutting-edge AI supercomputer powered by our AI infrastructure technology to help deliver transformative medicines."